Dallas-Fort Worth Life Sciences – BioTech Guide
  • Home
  • Ecosystem
  • Business Case
  • News
    • Relocations & Expansions
    • Investments
  • Contact
Category:

INVESTMENT

  • INVESTMENT

    Opsin Biotherapeutics Awarded $2.35 Million NIH Grant to Advance Optogenetic Neuromodulation for Chronic Pain

    by ddankesreiter@dallaschamber.org October 2, 2026
    by ddankesreiter@dallaschamber.org October 2, 2026

    Opsin Biotherapeutics, a pioneering biomedical technology company, announced a two-year, $2.35 million Phase II Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Institute …

    0 FacebookTwitterPinterestEmail
  • INVESTMENT

    MusiQ Bio Lands $2.6M CPRIT Grant for Cancer Immunotherapy

    by ddankesreiter@dallaschamber.org September 30, 2026
    by ddankesreiter@dallaschamber.org September 30, 2026

    Dallas-based biotech startup MusiQ Bio, a UT Southwestern Medical Center spinoff, received a $2.59 million state grant to advance new cancer treatments. Date: 2026-09-29 dallasinnovates.com/dallas-biotech-startup-lands-2-6m-grant-to-fight-cancer/ …

    0 FacebookTwitterPinterestEmail
  • INVESTMENT

    Astromech Raises $20M to Bring AI to Evolutionary Biology

    by ddankesreiter@dallaschamber.org August 20, 2026
    by ddankesreiter@dallaschamber.org August 20, 2026

    Astromech, the evolutionary biology AI company that spun out of Colossal Biosciences, has closed an additional $20 million in funding. To date, the company has raised $60 million and reports …

    0 FacebookTwitterPinterestEmail
  • INVESTMENT

    Forte Biosciences sells for $2.2B; Lincoln Property raises $400M – Dallas Business Journal

    by ddankesreiter@dallaschamber.org July 27, 2026
    by ddankesreiter@dallaschamber.org July 27, 2026

    Dallas-based biopharmaceutical company Forte Biosciences Inc. has agreed to be acquired by Dutch pharma giant Argenx SE for $2.2 billion, according to a July 27 announcement. www.bizjournals.com/dallas/news/2026/07/27/forte-biosciences-lincoln-property-deal-wrap.html

    0 FacebookTwitterPinterestEmail
  • INVESTMENT

    Dallas-Based Komen’s New $15.4M Grant Round Targets AI, Emerging Technologies, and Novel Breast Cancer Therapies » Dallas Innovates

    by ddankesreiter@dallaschamber.org June 25, 2026
    by ddankesreiter@dallaschamber.org June 25, 2026

    dallasinnovates.com/dallas-based-komens-new-15-4m-grant-round-targets-ai-emerging-technologies-and-novel-breast-cancer-therapies/ Dallas-based Susan G. Komen, the world’s leading breast cancer organization, recently awarded $15.4 million in grants to breast cancer researchers on the journey to unlocking the cures for all …

    0 FacebookTwitterPinterestEmail
  • INVESTMENTNEWSRELOCATION

    3 Life Sciences Companies Expand Pegasus Park Presence to Tower’s Top Floor » Dallas Innovates

    by ddankesreiter@dallaschamber.org June 4, 2026
    by ddankesreiter@dallaschamber.org June 4, 2026

    dallasinnovates.com/3-life-sciences-companies-expand-pegasus-park-presence-to-towers-top-floor/ The expansions by the companies—CG Oncology, Highlander Health, and LH Capital—are “strengthening the operational bridge that moves medical breakthroughs from the lab to the marketplace,” Pegasus Park said.

    0 FacebookTwitterPinterestEmail
  • INVESTMENT

    Alloy Therapeutics Raises $40M Series E for Biotech Infrastructure

    by ddankesreiter@dallaschamber.org May 12, 2026
    by ddankesreiter@dallaschamber.org May 12, 2026

    https://alloytx.com/alloy-therapeutics-announces-40m-series-e-to-scale-tech-enabled-biotech-infrastructure/ Alloy Therapeutics, Inc. (“Alloy”), a biotechnology ecosystem company powering the future of drug discovery and development through AI-driven platforms and integrated services, today announced a $40 million Series E …

    0 FacebookTwitterPinterestEmail
  • INVESTMENT

    Dallas’ Curve Biosciences Raises $40M for Its ‘Whole-Body Intelligence’ Disease Monitoring Platform

    by ddankesreiter@dallaschamber.org April 28, 2026
    by ddankesreiter@dallaschamber.org April 28, 2026

    A Plano-born biotech founder has returned to North Texas to establish the headquarters for his company, Curve Biosciences, at Pegasus Park, the nationally recognized life science and biotech innovation hub …

    0 FacebookTwitterPinterestEmail
  • INVESTMENT

    Argano acquires life sciences-focused Pharosity Consulting

    by ddankesreiter@dallaschamber.org February 17, 2026
    by ddankesreiter@dallaschamber.org February 17, 2026

    Plano’s Argano, a pioneering global consulting firm specializing in the design and delivery of high-performance business operations with an AI-forward approach to transformation, has acquired Pharosity Consulting, Inc. Based in …

    0 FacebookTwitterPinterestEmail
  • INVESTMENTNEWS

    ARPA-H Award to UTSW to Bioengineer Livers

    by ddankesreiter@dallaschamber.org January 14, 2026
    by ddankesreiter@dallaschamber.org January 14, 2026

    UT Southwestern Medical Center will get up to $25 million from the Advanced Research Projects Agency for Health (ARPA-H) to create fully functional, patient-specific artificial livers that could ease the …

    0 FacebookTwitterPinterestEmail
Newer Posts
Older Posts

Recent Posts

  • Opsin Biotherapeutics Awarded $2.35 Million NIH Grant to Advance Optogenetic Neuromodulation for Chronic Pain
  • Verily Health Selected to Build Data Platform for ARPA-H CIRCLE Program
  • UTSW receives ARPA-H award to create functioning artificial liver: Newsroom – UT Southwestern, Dallas, Texas
  • MusiQ Bio Lands $2.6M CPRIT Grant for Cancer Immunotherapy
  • MassChallenge Deepens Dallas Commitment with LHP

Recent Comments

No comments to show.

Social Connect

Facebook Twitter Instagram Pinterest Linkedin Youtube

Recent Posts

  • Opsin Biotherapeutics Awarded $2.35 Million NIH Grant to Advance Optogenetic Neuromodulation for Chronic Pain

  • Verily Health Selected to Build Data Platform for ARPA-H CIRCLE Program

  • UTSW receives ARPA-H award to create functioning artificial liver: Newsroom – UT Southwestern, Dallas, Texas

  • MusiQ Bio Lands $2.6M CPRIT Grant for Cancer Immunotherapy

  • MassChallenge Deepens Dallas Commitment with LHP

Categories

  • INVESTMENT (91)
  • NEWS (74)
  • RANKING (4)
  • RELOCATION (24)
  • Uncategorized (10)

CONTACT US

The Dallas Regional Chamber's Economic Development team serves as a single point of contact for companies, site selection consultants and corporate real estate executives examining the region for new and expanding companies.

  • Home
  • Ecosystem
  • Business Case
  • News
    • Relocations & Expansions
    • Investments
  • Contact
Dallas-Fort Worth Life Sciences – BioTech Guide
  • Home
  • Ecosystem
  • Business Case
  • News
    • Relocations & Expansions
    • Investments
  • Contact
  • Home
  • Ecosystem
  • Business Case
  • News
    • Relocations & Expansions
    • Investments
  • Contact